Genomic Characterization and Antibiotic Resistance Profiles of Acinetobacter baumannii Isolates From Intensive Care Units in Vietnam
- PMID: 40697769
- PMCID: PMC12283191
- DOI: 10.1155/ijm/7578951
Genomic Characterization and Antibiotic Resistance Profiles of Acinetobacter baumannii Isolates From Intensive Care Units in Vietnam
Abstract
Acinetobacter baumannii, an opportunistic pathogen, is responsible for a wide range of healthcare-associated infections (HAIs), particularly in patients in intensive care units (ICUs). Carbapenem-resistant A. baumannii (CRAB) is of particular concern due to its extensive multidrug resistance (MDR) and limited treatment options. In Vietnam, CRAB has become increasingly prevalent, with resistant mechanisms primarily attributed to the presence of blaOXA-23 and blaNDM-1 genes. This study investigates the clinical characteristics and genomic epidemiology of three CRAB isolates (ICU773, ICU400, and ICU399) from a tertiary-care hospital in Ho Chi Minh City. The isolates exhibited high resistance to a wide range of antibiotics, including carbapenems, aminoglycosides, and fluoroquinolones, while maintaining susceptibility to colistin. Whole-genome sequencing was used to analyze the genomic profiles, resistance genes, and sequence types of the isolates. All three isolates possessed blaOXA-23 and additional resistance genes such as blaADC and aminoglycoside-modifying enzymes (AMEs). MLST analysis revealed distinct genetic lineages, with ICU773 and ICU400 belonging to Sequence Types 2/195 and 2/Novel and ICU399 to Sequence Types 571/804. In silico analysis further identified several efflux pump genes and other resistance mechanisms, including the presence of the adeABC, adeFGH, and AbaQ pumps. These findings highlight the complexity of CRAB's genomic diversity and resistance mechanisms in the region, underscoring the urgent need for continuous surveillance and novel therapeutic strategies to combat this growing healthcare threat.
Keywords: carbapenem-resistant A. baumannii (CRAB); genomic epidemiology and resistance mechanisms; hospital-acquired infections.
Copyright © 2025 Thanh Truc Tran and Phuc Hoang Bui. International Journal of Microbiology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023.Microbiol Spectr. 2025 Jul;13(7):e0083225. doi: 10.1128/spectrum.00832-25. Epub 2025 Jun 9. Microbiol Spectr. 2025. PMID: 40488459 Free PMC article.
-
Comparative in vitro activities of eravacycline and tigecycline against carbapenem-resistant Acinetobacter baumannii: Insights from whole genome sequencing analysis.J Glob Antimicrob Resist. 2025 Jul 22;44:340-346. doi: 10.1016/j.jgar.2025.06.021. Online ahead of print. J Glob Antimicrob Resist. 2025. PMID: 40706997
-
Detection of Carbapenem-Resistant Genes Among Clinical Isolates of Acinetobacter baumannii in a Tertiary Care Hospital.Cureus. 2025 Jun 7;17(6):e85498. doi: 10.7759/cureus.85498. eCollection 2025 Jun. Cureus. 2025. PMID: 40625499 Free PMC article.
-
Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2024 Feb 28;13(1):24. doi: 10.1186/s13756-024-01376-7. Antimicrob Resist Infect Control. 2024. PMID: 38419112 Free PMC article.
-
Impact of antibiotic exposure on antibiotic-resistant Acinetobacter baumannii isolation in intensive care unit patients: a systematic review and meta-analysis.J Hosp Infect. 2024 Jan;143:123-139. doi: 10.1016/j.jhin.2023.11.002. Epub 2023 Nov 14. J Hosp Infect. 2024. PMID: 37972711
References
-
- Cogliati Dezza F., Covino S., Petrucci F., et al. Risk Factors for Carbapenem-Resistant Acinetobacter baumannii (CRAB) Bloodstream Infections and Related Mortality in Critically Ill Patients With CRAB Colonization. JAC-Antimicrobial Resistance . 2023;5(4) doi: 10.1093/jacamr/dlad096.dlad096 - DOI - PMC - PubMed
-
- Wareth G., Linde J., Hammer P., et al. Corrigendum to "Phenotypic and WGS-derived Antimicrobial Resistance Profiles of Clinical and Non-Clinical Acinetobacter baumannii Isolates From Germany and Vietnam" [International Journal of Antimicrobial Agents, Volume 56, Issue 4, October 2020, 106127] International Journal of Antimicrobial Agents . 2021;58(3) doi: 10.1016/j.ijantimicag.2021.106407.106407 - DOI - PubMed
-
- Meschiari M., Kaleci S., Orlando G., et al. Risk Factors for Nosocomial Rectal Colonization With Carbapenem-Resistant Acinetobacter baumannii in Hospital: A Matched Case-Control Study. Antimicrobial Resistance & Infection Control . 2021;10(1):p. 69. doi: 10.1186/s13756-021-00919-6. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources